MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dual device aided therapy for patients with advanced Parkinson’s Disease: A case series

A. Faust- Socher, G. Yahalom, M. Kestenbaum, A. Hilel, S. Israeli-Korn, A. Thaler, H. Strauss, H. Shabtai, S. Hassin-Baer, N. Giladi, T. Gurevich, O. Cohen (Tel Aviv, Israel)

Meeting: 2018 International Congress

Abstract Number: 344

Keywords: Deep brain stimulation (DBS)

Session Information

Date: Saturday, October 6, 2018

Session Title: Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To describe the benefits of adding levodopa–carbidopa intestinal gel infusion (LCIG) therapy to Parkinson’s disease (PD) patients on deep brain stimulation (DBS).

Background: Device-aided therapies for PD include DBS LCIG infusion via percutaneous gastrojejunostomy (PEG) and apomorphine subcutaneous infusion. They all aim at treating complications of oral dopaminergic medications such as motor fluctuations and dyskinesia. A recent study assessed the effect of LCIG therapy as an adjunctive treatment to advanced PD patients receiving DBS. After initial benefit with DBS some patients experience significant motor fluctuations with oral levodopa therapy suggesting potential benefit of adding infusion therapies.

Methods: We present a case series of PD patients from two movement disorder centers in Israel. All of the patients were initially treated with STN DBS with significant benefit. After further progression of their disease with poor control of symptoms, LCIG treatment was added.

Results: 7 patients (5=male) are presented in our series. 2 patients had an early onset PD. Symptoms duration from first PD symptoms to DBS was 6-12 years. Duration from DBS implantation to LCIG treatment initiation was 3-10 years. The patients had either unilateral (2) or bilateral (5) STN DBS and one patient also had additional bilateral GPI electrodes. In one patient PEG was also used for feeding. All patients improved after initiation of LCIG therapy. Most had reduced OFF time and/or reduction in ON time associated with troublesome dyskinesia. Motor symptoms such as freezing of gait improved as well. Non-motor symptoms which improved included pain, sleep, somnolence. However, balance and cognition did not improve as well as functional deficits in patients dependent on 24-hours caregiver help.

Conclusions: In the described case series, PD patients with advanced disease treated with DBS, had additional benefit from initiation of LCIG treatment. One observation is that addition of LCIG therapy may be helpful for adjustment of levodopa in patients stimulated unilaterally. In an era of personalized medicine for PD patients, combining advanced treatments can have a significant impact on patient’s symptoms and disability.

References: Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation-Refractory Symptoms in Advanced Parkinson Disease. Regidor I, Benita V, Del Álamo de Pedro M, Ley L, Martinez Castrillo JC. Clinical Neuropharmacology. 2017 May/Jun;40(3):103-107.

To cite this abstract in AMA style:

A. Faust- Socher, G. Yahalom, M. Kestenbaum, A. Hilel, S. Israeli-Korn, A. Thaler, H. Strauss, H. Shabtai, S. Hassin-Baer, N. Giladi, T. Gurevich, O. Cohen. Dual device aided therapy for patients with advanced Parkinson’s Disease: A case series [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/dual-device-aided-therapy-for-patients-with-advanced-parkinsons-disease-a-case-series/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/dual-device-aided-therapy-for-patients-with-advanced-parkinsons-disease-a-case-series/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley